AUTONOMIX MEDICAL INC (AMIX) Stock Price, Forecast & Analysis
USA - NASDAQ:AMIX - US05330T2050 - Common Stock
AMIX Key Statistics, Chart & Performance
The current stock price of AMIX is 0.7082 USD. In the past month the price decreased by -25.01%. In the past year, price decreased by -92.73%.
AMIX Latest News, Press Relases and Analysis
AMIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.88 | 224.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.96 | 203.59B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.69 | 156.01B | ||
| SYK | STRYKER CORP | 28.42 | 143.11B | ||
| IDXX | IDEXX LABORATORIES INC | 55.61 | 56.10B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.59 | 50.69B | ||
| RMD | RESMED INC | 25.58 | 36.95B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.16 | 33.87B | ||
| PODD | INSULET CORP | 72.85 | 23.43B | ||
| DXCM | DEXCOM INC | 32.18 | 23.47B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.16 | 17.89B |
Related stock screener links
About AMIX
Company Profile
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Company Info
AUTONOMIX MEDICAL INC
21 Waterway Ave, Suite 300
The Woodlands TEXAS US
Employees: 10
Phone: 18322777816
AUTONOMIX MEDICAL INC / AMIX FAQ
Can you describe the business of AUTONOMIX MEDICAL INC?
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. The company is headquartered in The Woodlands, Texas and currently employs 8 full-time employees. The company went IPO on 2024-01-29. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The firm is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
What is the stock price of AUTONOMIX MEDICAL INC today?
The current stock price of AMIX is 0.7082 USD. The price decreased by -16.43% in the last trading session.
Does AUTONOMIX MEDICAL INC pay dividends?
AMIX does not pay a dividend.
What is the ChartMill rating of AUTONOMIX MEDICAL INC stock?
AMIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of AUTONOMIX MEDICAL INC (AMIX)?
AUTONOMIX MEDICAL INC (AMIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.81).
What is the market capitalization of AMIX stock?
AUTONOMIX MEDICAL INC (AMIX) has a market capitalization of 4.38M USD. This makes AMIX a Nano Cap stock.
AMIX Technical Analysis
AMIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AMIX. While AMIX has a great health rating, there are worries on its profitability.
AMIX Financial Highlights
Over the last trailing twelve months AMIX reported a non-GAAP Earnings per Share(EPS) of -6.81. The EPS increased by 48.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -133.9% | ||
| ROE | -171.32% | ||
| Debt/Equity | 0 |
AMIX Forecast & Estimates
8 analysts have analysed AMIX and the average price target is 6.73 USD. This implies a price increase of 850.58% is expected in the next year compared to the current price of 0.7082.